Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01, R03 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages grant applications from institutions or organizations that propose multidisciplinary, investigator-initiated basic translational and clinical research in developmental pharmacodynamics. This FOA seeks grant applications that propose studies to increase and establish data on developmental pharmacodynamics in the pediatric age groups and allows the determination of pharmacokinetic-pharmacodynamic relationship of drugs used in this population.  

Although this funding opportunity uses the R01 grant mechanism, it runs in parallel with a program announcement of identical scientific scope, PA-18-687, for R03 small grants.


  • Letter of Intent: 30 days prior to the application due date
  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
  • R03 Due Dates: Feb. 16, Jun. 16, Oct. 16
  • AIDS Due Dates: Jan. 7, May 7, Sep. 7

PA-18-688 Expiration Date May 8, 2021




Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 5, 2021